ClinicalTrials.Veeva

Menu

The COMPLETE Treatment of Bifurcation With Two-stent Techniques: Randomized Comparison of Crush Versus Culotte Technique

Yonsei University logo

Yonsei University

Status

Enrolling

Conditions

Coronary Artery Disease

Treatments

Device: Crush technique
Device: Culotte technique

Study type

Interventional

Funder types

Other

Identifiers

NCT05488665
1-2022-0033

Details and patient eligibility

About

In this COMPLETE randomized trial, using the contemporary second-generation drug-eluting stent, we aimed to test whether the crush technique is superior to the culotte technique for the treatment of bifurcation lesions in terms of 1-year target-lesion failure.

Enrollment

512 estimated patients

Sex

All

Ages

19+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria:

  1. Age ≥19 years
  2. De novo coronary lesions eligible for drug-eluting stent implantation
  3. Medina 1,1,1 or 1,0,1 or 0,1,1 de novo bifurcation lesions (LM or non-LM) and those of main vessel or side branch can be covered by 2 stents
  4. Reference vessel diameter of side branch ≥2.5 mm by visual estimation

Exclusion criteria

  1. Current or potential pregnancy
  2. Inability to follow the patient over the period of 1 year after enrollment, as assessed by the investigator
  3. Subjects with ST elevation myocardial infarction <24 h from the onset of chest pain
  4. Cardiogenic Shock

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

512 participants in 2 patient groups

Crush technique group
Experimental group
Description:
Two stenting with the Crush technique
Treatment:
Device: Crush technique
Culotte technique group
Active Comparator group
Description:
Two stenting with the Culotte technique
Treatment:
Device: Culotte technique

Trial contacts and locations

1

Loading...

Central trial contact

Byeong-Keuk Kim, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems